Parody-Rua, Elizabeth http://orcid.org/0000-0001-8219-2568
Bustamante, Alejandro http://orcid.org/0000-0003-4390-8900
Montaner, Joan http://orcid.org/0000-0003-4845-2279
Rubio-Valera, Maria http://orcid.org/0000-0003-2856-1697
Serrano, David
Pérez-Sánchez, Soledad http://orcid.org/0000-0002-8940-9763
Sánchez-Viñas, Alba http://orcid.org/0000-0001-5020-7534
Guevara-Cuellar, César http://orcid.org/0000-0002-4412-0261
Serrano-Blanco, Antoni http://orcid.org/0000-0001-6123-0633
Funding for this research was provided by:
Instituto de Salud Carlos III (PMP15/00022, CP19/00029)
Biomarkers for Initiating Onsite and Faster Ambulance Stroke Therapies (DTS19/00135)
Research Network on Preventative Activities and Health Promotion (RD16/0007/0012)
European Regional Development Fund
Centro de Investigación Biomedica en Red de Epidemiología y Salud Pública (CB16/02/00322)
Generalitat de Catalunya (SLT006/17/68)
Universitat de Barcelona
Article History
Received: 18 October 2021
Accepted: 21 June 2022
First Online: 27 July 2022
Declarations
:
: Dr. Montaner holds patents on “METHOD FOR SELECTING A PATIENT FOR A REPERFUSION THERAPY” EP19382384.6 and “METHODS FOR DIFFERENTIATING ISCHEMIC STROKE FROM HEMORRHAGIC STROKE” EP14382492. The other authors report no conflicts.